Week 2 - Endocrine Disorders Flashcards

1
Q

Describe the structure and microscopy of the pituitary gland.

A

• Normal pituitary gland - extension of hypothalamus.
• Anterior glandular portion and posterior neural portion.
• Anterior pituitary - develops from Rathke’s pouch - epithelium of the nasal cavity joins with the neural crest (diencephalon) - together they form pituitary gland.
Microscopy:
• Anterior pituitary - all endocrine glands. 3 types of cells - basophilic blue cells, acidophilic red cells and clear cells (chromophobes).
• Posterior pituitary - astrocytes and axons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the hypothalamo-pituitary axis.

A
  • Hypothalamus controls pituitary. Hormones controlled by interconnected feedback mechanisms but there is a strong neural control - GHRH, CRH, TRH, GnRH, ADH, oxytocin.
  • Hypothalamic nuclei controlled by a range of factors e.g. hunger, thirst, emotions etc. → control endocrine system.
  • Anterior pituitary - through nerves and hypophyseal portal circulation → release anterior pituitary hormones - GH, ACTH, TSH, FSH, LH, PRL.
  • Posterior pituitary - direct release of hormones into the capillaries (axons carry the NTs and hormones which are directly released into capillaries) - ADH, oxytocin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline pituitary function and disorders.

A

CELL/ADENOMA - HORMONE - ASSOCIATED SYNDROME:
• Lactotroph - Prolactin (Prolactinoma):
- Galactorrhoea and amenorrhoea (females), sexual dysfunction, infertility.
• Somatotroph - GH:
- Gigantism (children), acromegaly (adults).
• Mammosomatotroph - GH + PRL:
- Combined features.
• Corticotroph - ACTH:
- Cushing’s disease.
- Nelson syndrome (post adrenolectomy - adenoma).
• Thyrotroph - TSH:
- Secondary hyperthyroidism.
• Gonadotroph - FSH, LH:
- Hypogonadism and hypopituitarism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the commonest cause of hyperpituitarism?

A

Adenoma - Prolactinoma (most common adenoma).

Gonadotroph adenoma least common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the commonest cause of hypopituitarism?

A

Injury/infarction - trauma, tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline pituitary adenoma.

A
  • Most common cause of hyperpituitarism in the anterior lobe.
  • Classified based on the hormone(s) produced by the neoplastic cells - prolactin > GH > both > ACTH (Cushing’s) > TSH > FSH/LH. (Prolactin commonest producing hormone, least is gonadotropin).
  • 95% sporadic, 5% familial.
  • Due to G-Protein mutations - accumulation of genetic damage → formation of a tumour in the pituitary.
  • Can be functional (symptoms associated hormone excess) or non-functional (no clinical symptoms).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the morphology of pituitary adenoma.

A
Gross:
• Microadenoma < 10mm (90%).
- More common in females 10:1.
- Functional - produce hormones.
- Very small tumours, may get calcified.
• Macroadenoma > 10mm (10%).
- More common in males.
- Non-functional (therefore, diagnosed at later stage - tumour has grown large).
- Large non-functioning tumours may cause hypopituritarism as destroy adjacent tissue.
Microscopy:
• Uniform one type of cell. 
• Normal pituitary - lots of cells. Adenoma - only one type of cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the clinical features of pituitary adenoma?

A
  • Signs and symptoms are related to both endocrine abnormalities (excess hormone secretion) and mass effects.
  • Females - amenorrhoea, galactorrhoea, infertility (hormone features).
  • Males - headache, visual loss (mass effects), hypogonadism and infertility.
  • Excess hormone secretion e.g. hyperthyroidism, Cushing’s syndrome, gigantism/acromegaly, galactorrhoea.
  • Mass effects e.g. headache, lethargy, nasal drainage, nausea/vomiting, change in sense of smell and vision.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outline somatotroph adenoma.

A
  • Second common.
  • GH +/- prolactin. (GH hormone producing adenoma. Rarely can also produce both prolactin and GH).
  • Produces gigantism/acromegaly.
  • Persistently elevated levels of GH stimulates hepatic secretion of insulin like growth factor 1 (somatostatin C) → produces clinical features of excess growth e.g. large hands and feet, prominent lower jaw, enlarged head circumference, organomegaly, accelerated osteoporosis, hyperglycaemia.
  • May also have diabetes mellitus, CCF, arthritis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the aetiology/pathogenesis of Sheehan’s syndrome.

A

Post partum anterior pituitary necrosis (hypopituitarism):
• Ischaemic necrosis of the anterior pituitary during childbirth → hypopituitarism.
1. During pregnancy, the anterior pituitary enlarges to almost twice its normal size.
2. The gland expansion is not accompanied by increase in venous blood supply (relative anoxia).
3. Further reduction in blood supply (due obstetric haemorrhage -bleeding/ shock) may precipitate infarction of the anterior lobe (not posterior as this receives blood from arterial branches).
4. Ischaemic area is reabsorbed & replaced by fibrosis tissue.

No arteries in the anterior pituitary (hypophyseal portal system only). Physiologic hypertrophy + shock/bleeding → necrosis → hypopituitarism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Identify the clinical features and management of Sheehan’s syndrome.

A

• Symptoms (due to sudden loss of anterior pituitary hormones):
- Inability to breast-feed (due to lack of PRL).
- Severe fatigue, depression.
- Lack of menstrual bleeding (due to lack of FSH/LH).
- Loss of pubic and axillary hair (due to lack of FSH/LH).
- Low blood pressure (hypotension).
• Management - hormone replacement therapy - replace estrogen, progesterone, thyroid and adrenal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline hypopituitarism.

A
  • 75% of anterior pituitary loss and/or with posterior pituitary loss → decreased pituitary function (hypopituitarism).
  • Combined anterior and posterior (diabetes insipidus) → hypothalamic (suspect hypothalamic disorder).
  • Congenital or acquired (tumours, injury, necrosis). “Empty sella syndrome”.
  • Craniopharyngioma (tumour of epithelium from Rathke’s pouch) or Glioma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Identify the clinical features of hypopituitarism.

A

• Clinical features based on the hormone involved.
- GH: pituitary dwarfism (proportional dwarf) - hands and limbs equally affected, symmetric.
- FSH/LH: infertility, impotence.
- TSH: hypothyroidism.
- MSH: pallor (melanocytes) - MSH usually produced with ACTH - severe pallor (loss of melanocytes function).
- ACTH: hypo-adrenalism.
- Posterior pituitary loss: diabetes insipidus.
• Diabetes insipidus with any of the above - suspect hypothalamic disorder (combined).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the most common dwarfs?

A
  1. Achondroplasia.
  2. Turner syndrome.
  3. Pituitary dwarf - proportional.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 2 types of posterior pituitary disorders?

A
  • Syndrome of inappropriate ADH secretion (SIADH) - decreased urine.
  • Diabetes insipidus - diuresis/polyuria - tasteless increased urine. Excessive thirst (polydipsia).
  • Both conditions can occur with CNS injury, trauma, tumours.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe SIADH.

A
  • Increased ADH.
  • Water intoxication (water retention - body stores water).
  • Low serum sodium.
  • High urine osmolality (urine becomes too concentrated).
  • Causes: drugs, ARDS, sepsis, tumours, trauma, CNS inflammation, stroke.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe diabetes insipidus.

A

• Decreased ADH.
• Dehydration (diuresis/polyuria - body loses water).
• High serum sodium.
• Low urine osmolality (low sodium).
• Causes (low ADH or decreased response to ADH):
- Central - CNS trauma, inflammation, stroke, tumour.
- Renal - tubular resistance to ADH. CRF, lithium, hereditary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outline the composition and function of the thyroid gland.

A

• Iodinated tyrosines (amino acids), stored in colloid - thyroglobulin.
• Breakdown of protein to release T3 and T4 is through endocrine control (TRH > TSH > T4, T3).
• Metabolism: increased BMR, increased oxygen, increased fat and carb mobilisation and utilisation.
• Growth and development:
- CVS - increased rate, increased blood flow.
- CNS - increased mental activity.
- GIT - increased motility.
• Iodine excess inhibits thyroglobulin proteolysis and release of T4 and T3 - therapy for thyrotoxicosis.
• C cells - calcitonin producing cells. Cluster of cells in between the follicles. Bone forming (opposite effect of PTH).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the hypothalamic-pituitary-thyroid axis.

A
  • Hypothalamus produces TRH → pituitary produces TSH → TSH binds to G protein receptors → Release of T3/T4 hormones → T3/T4 bind to nuclear receptors in the target cell (every cell in the body requires thyroid hormone).
  • Thyroid hormone stimulates cellular gene expression and metabolism. Metabolism is a major activity of thyroid gland.
  • T3 is the final metabolically active product. T4 gets converted peripherally (not in gland).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Outline the aetiology of hyperthyroidism.

A

• Hyperthyroidism (thyrotoxicosis) describes the clinical features arising from elevated levels of thyroid hormone (free T4 & T3).
Aetiology:
• Primary Hyperthyroidism → hyperfunciton of the thyroid gland (most common cause) due to:
- Graves Disease (causing diffuse hyperplasia of the thyroid - 85% of cases).
- Toxic Multinodular Goitre.
- Functioning adenoma of the thyroid.
• Secondary Hyperthyroidism → extrathyroidal cause (e.g. at level of pituitary/hypothalamus).

• Commonest cause of hyperthyroidism:

  1. Primary, autoimmune - Graves.
  2. Iodine deficiency, toxic change in a tumour (MNG).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the pathogenesis of hyperthyroidism.

A
  1. Hyperfunction of the thyroid leads to increased levels of thyroid hormone (T4 & T3).
  2. Increased thyroid hormone causes increased cellular metabolism.
  3. This results in the clinical features observed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the clinical features of hyperthyroidism?

A

Hypermetabolism which leads to:
• Weight loss despite increased appetite.
• Skin: soft, warm flushed, heat intolerance.
• CVS: increased HR/CO, palpitations, AF.
• Neuromuscular: tremor, hyperactivity, anxiety, inability to concentrate, insomnia, increased reflexes.
• GIT: diarrhoea, increased motility.
• Ocular: wide, staring gaze, lid lag/retraction, exophthalmos/proptosis - only in Graves.
• Reproductive: menorrhagia
• Musculoskeletal: osteoporosis, proximal myopathy.
• Other: acropachy (congenital clubbing), onycholysis, pretibial myxoedema, hair loss, goitre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is thyroid storm?

A

Acute condition - sudden severe hyperthyroidism in a patient with Grave’s or other hyperthyroidism - produces severe fever, tachycardia, AF, arrhythmia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Outline the aetiology of hypothyroidism.

A

• Hypothyroidism describes the clinical features arising from low levels of thyroid hormone (free T4 & T3). Is common (with prevalence increasing with age & women).
Aetiology:
• Can be primary (thyroid), secondary (pituitary) or tertiary (hypothalamus).
• Caused by any structural/functional derangement interfering with production of thyroid hormone.
• Commonest cause of hypothyroidism:
1. Primary, autoimmune thyroiditis - Hashimotos.
2. Iodine deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the pathogenesis of hypothyroidism.

A
  1. Hypofunction of the thyroid leads to decreased levels of thyroid hormone (T4 & T3).
  2. Decreased thyroid hormone causes decreased cellular metabolism.
  3. This results in the clinical features observed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the clinical features of hypothyroidism?

A
  • Dry, coarse, thin hair.
  • Loss of outer third of eyebrows.
  • Weight gain.
  • Diminished sweating.
  • Dry, cold skin - prone to hypothermia (cold intolerance).
  • Constipation.
  • Apathy, fatigue, mental sluggishness.
  • Menstrual irregularities.
  • Hoarse voice.
  • Pretibial myxoedema.
  • Periorbital oedema.
  • Ischaemic heart disease, bradycardia.
  • Muscle weakness.
  • Decreased reflexes.
  • Goitre.
  • Yellow skin (carotene not jaundice).
  • Carpal tunnel syndrome.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is cretinism?

A

• Hypothyroidism in infancy/congenital leading to:
- Mental retardation
- Protruding tongue
- Short stature (dwarfism)
- Umbilical hernia
- Jaundice, dry skin, slow reflexes, hoarse voice.
• Endemic - iodine deficiency.
• Sporadic - enzyme deficiency/congenital.
• Used to be common in endemic areas due to iodine deficiency but now usually due to congenital atrophy/agenesis or enzyme deficiency.

  • Cretinism - hypothyroidism which develops in infancy or early childhood.
  • Myxedema - hypothyroidism developing in the older child or adult.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Outline Hashimotos thyroiditis.

A
  • Commonest cause of non endemic goiter (endemic - iodine deficiency).
  • Autoimmune destructive thyroiditis → hypothyroidism.
  • Common in later age group (45-65yo), females more common (10-20:1) but can occur in any age, sex and children.
  • Patients can also have other autoimmune disease - T1DM, RA.
  • B cell lymphoma and papillary carcinoma can occur.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the aetiology of Hashimotos thyroiditis/Graves disease?

A
  • Genetic - HLA DR3/5, CTLA4, PTPN22.
  • Environmental - viral.
  • Autoimmunity - TSI, ATG Ab, ATP, AMAb.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe the pathogenesis of Hashimotos thyroiditis.

A
  1. Production of antithyroid antibodies (antithyroglobulin Ab & antithyroid peroxidise Ab).
  2. Autoimmune destruction of the thyroid gland due to antibodies, CD8 cells and cytokines → gradual thyroid failure.
  3. Decreased thyroid hormone results in hypothyroidisim.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Outline the morphology of Hashimotos thyroiditis.

A

Gross:
• Gland diffusely enlarged/goitre.
• Firm, pale grey gland.
• Intact capsule & gland is well demarcated.
Microscopy:
• Extensive infiltration by inflammatory cells.
• Atrophic thyroid follicles.
• Lymphocytes (forming lymphoid follicles).
• Dark colloid, no vacuoles.

32
Q

What are the clinical features of Hashimotos thyroiditis?

A
  • Painless enlargement of the thyroid.

* Symptoms of hypothyroidism.

33
Q

Outline Graves disease.

A

• Common cause of hyperthyroidism.
• More common in females aged 20-40yo.
• Autoimmune non-destructive stimulating thyroiditis.
• Triad of clinical features:
- Hyperthyroidism, vascular enlarged thyroid.
- Infiltrative ophthalmopathy - exophthalmos.
- Dermatopathy, pretibial myxoedema (minority).
• TSH receptor stimulating Ig. TSI/LATS (mixture of Ab).

34
Q

Describe the pathogenesis of Graves disease.

A
  1. Production of IgG antibodies against the TSH receptor on the thyroid follicular cell.
  2. Autoantibodies stimulate thyroid hormone production & proliferation of follicular cells
  3. Increased thyroid hormone results in hyperthyroidism.
35
Q

Outline the morphology of Graves disease.

A
Gross:
• Symmetrically enlarged thyroid gland.
• Red, soft, smooth, hyperaemic gland.
• Gland becomes highly vascular. 
• Bruit on auscultation.
Microscopy:
• Diffuse follicular hyperplasia (large follicles with papillary epithelial hyperplasia).
• Vacuolated pale, scanty colloid.
• Few lymphocytes (inflammation).
36
Q

What are the clinical features of Graves disease?

A

Triad of clinical features:
• Features of hyperthyroidism.
• Infiltrative ophathalmopathy with resultant exophthalmos.
• Localised infiltrative dermatopathy (pretibal myxedema - scaly thickening of skin).

37
Q

What is subacute granulomatous thyroiditis?

A
  • AKA De Quervain thyroiditis.
  • Subacute, painful, fever, fatigue - viral/post viral (usually secondary to viral infection).
  • Less common, females, 30-60 years.
  • Hyperthyroidism - but low iodine uptake (release).
  • Heals with normal thyroid function (initially hyperthyroidism but then heals with normal thyroid function).
  • Microscopically shows granulomas like TB (but not an infection).
38
Q

What is subacute lymphocytic thyroiditis?

A
  • Subacute, silent/painless.
  • Females, middle age, commonly postpartum (pregnancy induced thyroiditis).
  • Initial thyrotoxicosis → euthyroid in months.
  • Minority progress to hypothyroidism.
39
Q

Identify the stimulating, blocking and destructive factors involved in the etiopathogenesis of autoimmune thyroiditis.

A
  • Stimulating factors: LATS
  • Blocking factors: IFN-γ
  • Destructive factors: CTL

Graves - increased stimulating factors.
Hashimotos - increased blocking/destructive factors.

40
Q

Outline thyroid function tests.

A
  • Graves - decreased TSH, increased T3 and T4.
  • Hashimotos - increased TSH, decreased T3 and T4.
  • Central hyperthyroidism (not common condition) - excess thyroid function due to pituitary hyperplasia or hyperpituitarism - TSH, T3 and T4 all increased.
  • Central hypothyroidism - hypopituitarism, Sheehan’s syndrome - TSH, T3 and T4 all decreased.
  • TSH is the most sensitive and earliest abnormality (even before the hormones get effected). Therefore, measurement of TSH is the most important clinically when you suspect disease → T3 and T4 to confirm.
  • All adults >35y should have their serum TSH measured and repeated every 5 years.
41
Q

Outline thyroid tumours.

A
  • Enlargement of the thyroid (goitre) is the most common manifestation of thyroid disease.
  • Can be subdivided as: non-neoplastic (95%) and neoplastic (5%).
  • Non-neoplastic - diffuse and multinodular goitre, hyperplasia, inflammation, infection, cysts.
  • Neoplastic - follicular adenoma, papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma. Mainly in young males. If hot, generally benign.
42
Q

Differentiate between non-neoplastic and neoplastic thyroid tumours.

A
Non-neoplastic:
• Common (95%).
• Diffuse enlargement/multiple nodules.
• Common in middle age, females.
• MNG, autoimmune thyroiditis, infections and cysts.
Neoplastic:
• Uncommon.
• Solitary nodule in a normal thyroid.
• Common in young, males.
• Adenoma, carcinoma.
43
Q

Outline multinodular goitre.

A
  • Most common goitre clinically.
  • Enlargement of thyroid - commonest cause of thyroid swelling.
  • Enlargement of thyroid without functional, inflammatory or neoplastic alterations.
  • Reflect impaired synthesis of thyroid hormone (often due to dietary iodine deficiency).
  • Can be both endemic and sporadic types (sporadic rare, usually young females).
  • Scan - uneven iodine uptake (characteristic feature of MNG is uneven iodine uptake).
  • Prognosis - small risk of cancer (follicular).
44
Q

Describe the aetiology of multinodular goitre.

A
  • Endemic - > 10% of population - iodine deficiency, high altitude areas (Andes, Himalayas).
  • Sporadic - occurs due to enzyme deficiencies, drugs, food (cabbage, cassava - Fiji - inhibits iodine absorption), thiocyanates, congenital deficiencies.
45
Q

What is the pathogenesis of multinodular goitre.

A
  • Aetiological cause e.g. iodine/enzyme deficiency → results in decreased T3, T4 production → stimulates pituitary for increased TSH. TSH is a proliferative hormone → induces hyperplasia of the gland.
  • Gland hyperplasia compensates for function → euthyroid state (normal thyroid state).
  • Initially diffuse (colloid) goitre → repeated attacks → multinodular.
  1. Low iodine → impaired thyroid hormone synthesis → compensatory rise in serum TSH.
  2. Increased TSH causes hypertrophy and hyperplasia of thyroid follicular cells.
  3. Result is gross enlargement of the thyroid gland → diffuse goitre.
  4. Usually, compensatory mechanism can overcome hormone deficiency (euthyroid state).
  5. Usually regresses but in some cases unknown stimulus to thyroid enlargement persists and the glands become multinodular → multinodular goitre.
46
Q

What are the complications of multinodular goitre?

A
  • Toxic change in a nodule - Plummer syndrome (toxic multinodular goitre) - an autonomous nodule may develop within a long-standing goitre and produce hyperthyroidism (without infiltrative ophthalmopathy/ dermatopathy) - rare.
  • Small risk of cancer - follicular cancer known to occur in endemic populations.
47
Q

Identify the clinical features of multinodular goitre.

A

• Thyroid enlargement with the absence of thyroid dysfunction or positive autoantibodies.
• Most patients are in an euthyroid state.
• Clinical features generally related to the mass size/effect:
- Difficulty swallowing (dysphagia).
- Airway obstruction
- Superior vena cava syndrome (compression of large vessels in neck/upper thorax).

48
Q

Describe the morphology of multinodular goitre.

A

Gross:
•Extreme thyroid enlargement (both lobes, asymmetrical).
•Multiple nodules.
Microscopy:
• Nodules of hyper plastic follicles (variation in size).
• Colloid rich follicles (accumulation of colloid).
• Areas of inflammation, haemorrhage, fibrosis, necrosis, calcification etc.

49
Q

Outline neoplasms of the thyroid.

A

• 90:10:1 - MNG:Adenoma:Carcinoma
- 90% of nodules in thyroid - MNG, iodine deficiency or non-neoplastic.
- 10% are benign adenomas.
- <1% carcinomas.
• Adenoma - benign tumour - hot/cold (rare).
- When doing radioiodine studies (scan) - if it shows activity (hot nodule), if it does not show activity (cold nodule).
- Hot nodules usually benign (functional - producing T3, T4 - thyrotoxicosis).
- Cold nodules can be benign but can also be malignant.
• Papillary carcinoma - >85%, young, solitary, good prognosis (98% 10 year survival when localised).
• Follicular carcinoma - 5-15%, aged, small primary, early BV spread, haematogenous. Female, endemic areas.
• Medullary carcinoma - 5%, carcinoma of C cells, calcitonin, associated with MEN syndrome.
• Anaplastic carcinoma - <5%, high grade cancer occurring in later age, very rare.

50
Q

Outline follicular adenoma.

A

• Discrete, solitary unilateral mass derived from follicular epithelium.
• Cold/non functional.
• Rarely hot/functional.
- Hot nodule → not carcinoma.
- When it is functional - may induce thyrotoxicosis.
- Often secretes excess thyroid hormone & inhibits TSH secretion (but majority are non functional).
• 10% are malignant.
• Mutations of TSH receptor signaling pathway in toxic adenoma and MNG.
- Genetic alterations in these adenomas are usually TSH receptor signaling pathway mutations → mutations leading to uncontrolled activation of TSH receptors → results in excess secretion of thyroid hormone. Seen in both adenomas and MNG.

51
Q

Outline papillary carcinoma.

A
  • Commonest (85%), may be a history of past radiation.
  • Young 25-50y.
  • BRAF mutation - usually associated with BRAF mutation - protein kinase pathway (carcinogenesis) - seen in many other malignancies as well.
  • Localised, cystic, calcification (psammoma bodies).
  • Papillary structures with fibrovascular cores - characteristic feature.
  • Good prognosis - 98% 10y survival for early stages (when diagnosed early).
52
Q

Describe the structure of the adrenal gland.

A
• Located on top of the kidney.
Adrenal gland - 2 different components:
• Outer cortex - epithelial gland
- Steroid hormones
• Inner medulla - neural - secretes neurotransmitters - 3 zones
- Glomerulosa (outer).
- Fasciculata (middle).
- Reticularis (inner).
53
Q

Outline the composition and secretions of the adrenal gland.

A

• Cortex zones (gland):
- Glomerulosa - mineralocorticoids - aldosterone.
- Fasciculata - glucocorticoids - cortisone.
- Reticularis - gonadotrophins - androgen and estrogens (sex steroids).
• Medulla (neural):
- Chromaffin cells and sympathetic nerve endings - epinephrine.
- Sympathetic system - produce epinephrine and norepinephrine.

ACTH stimulates cortex → uses cholesterol as ingredient to produce lipid hormones known as steroids. Steroids (mainly cortisol) have negative inhibition on ACTH.

54
Q

Identify the common disorders of the adrenal gland.

A

Cortex:
• Hyperfunction:
1. Primary hyperaldosteronism (glomerulosa)
2. Cushing’s syndrome and disease (fasciculata)
3. Congenital adrenal hyperplasia (reticularis)
• Hypofunction:
1. Acute - Waterhouse Fridrichsen syndrome
2. Chronic - Addison’s
Medulla:
• Pheochromocytoma (tumor of adrenal medulla).

55
Q

What is Cushing’s syndrome and disease?

A
  • Cushing’s Syndrome - disorder of the adrenal glands in which there is an excess of glucocorticoids/cortisol.
  • Cushing’s Disease - subtype of Cushing’s syndrome caused by ACTH-secreting pituitary adenoma.
56
Q

Outline the aetiology of Cushing’s syndrome.

A

• Exogenous: Cushing’s syndrome
- Steroid therapy (most common cause clinically) - due to prolonged administration of glucocorticoids (e.g. prednisolone) - iatrogenic.
• Endogenous: Cushing’s disease
- Pituitary ACTH adenoma 70% - producing too much steroid hormones particularly glucocorticoids - commonest endogenous cause.
- Ectopic ACTH 10% - SCC (occasionally tumours like SCC of lung can produce ACTH).
- Adrenal adenoma 10% (can produce ACTH).
- Adrenal carcinoma 5%.

  • In exogenous - there is atrophy of the adrenal gland.
  • In endogenous - there is hypertrophy of the adrenal gland.
57
Q

What are the clinical features of Cushing’s syndrome?

A
  • Hypertension.
  • Truncal obesity.
  • Myopathy.
  • Diabetes mellitus (hyperglycaemia).
  • Osteoporosis (causing fractures).
  • Hair thinning.
  • Hirsutism
  • Acne
  • Plethora
  • Cataracts/mild exophthalmos.
  • Moon face.
  • Buffalo hump.
  • Peptic ulcer.
  • Renal stones.
  • Menstrual disturbance.
  • Tendency to infections (due to poor wound healing and little inflammatory response).
  • Psychosis.
  • Striae.
  • Decreased skin thickness.
  • Muscle wasting.
  • Bruising.
58
Q

Outline the diagnosis of Cushing’s syndrome.

A

• Measure ACTH and cortisol levels:

  • 24 hour urine cortisol level - increased free urine cortisol (does not decrease with low dexamethasone).
  • Loss of normal diurnal pattern of cortisol secretion (normally high morning, low night).
  • Serum ACTH - to differentiate between exogenous and endogenous. Cushing’s syndrome = decreased ACTH. Cushing’s disease = increased ACTH.

• Dexamethosone suppression test

  • Normal: cortisol depressed.
  • Cushing’s syndrome: ACTH undetectable/low, cortisol not suppressed by high or low doses.
  • Cushing’s disease: ACTH normal to elevated but not in hundreds, cortisol suppressed by high doses (not low doses).
  • Ectopic ACTH: ACTH elevated in hundreds, cortisol not suppressed by high or low doses
  • MRI brain - pituitary adenoma
  • CT chest/pelvis - ectopic e.g. SCC.
  • CT abdo - adrenal adenoma (if ACTH undetectable).
  • BSL - hyperglycemia.
  • FBC, U+Es.
  • Careful drug history to exclude iatrogenic causes.
59
Q

Outline primary hyperaldosteronism.

A

• Aetiology:
- Idiopathic - 60% nodular hyperplasia. Later age, moderate hypertension.
- Aldosterone adenoma - 35% benign tumour (Conn’s syndrome). Middle age, women 2:1, severe hypertension.
• Suppress renin-angiotensin mechanism.
• K+ loss, Na+ retention (increased reabsorption into blood) → hypertension.
• 5-10% of hypertension patients, common secondary hypertension. Resistant to treat.
• Diagnosis - hypokalemia, increased aldosterone (decreased renin).

*Hypokalemia in a hypertensive patient - think primary hyperaldosteronism.

60
Q

Outline adrenogenital syndrome.

A

• Commonest 90%.
• 21-Hydroxylase deficiency.
- Required for the production of both mineralocorticoids and glucocorticoids.
- Deficiency → pregnenolone diverted towards producing testosterone.
• Decreased cortisol - increased ACTH → congenital adrenal hyperplasia.
- increased ACTH leads to hyperplasia of adrenal gland.

61
Q

What are the clinical types of adrenogenital syndrome?

A
  1. Salt wasting syndrome (Na+ loss, K+ retention).
  2. Simple virilising* increased testosterone.
    • Commonest is virilising - excess testosterone effects in newborn baby - born with more prominent male genitalia/prominence of clitoris - due to excess testosterone).
  3. Late onset adult virilism - partial deficiency.
62
Q

What are the causes of acute adrenocortical insufficiency?

A
  • Long term steroid therapy - sudden withdrawal.
  • Crisis in a chronic insufficiency patient (Addison’s).
  • Waterhouse-Friderichsen Syndrome (most important).
63
Q

Identify the clinical features of acute adrenocortical insufficiency?

A
Sudden decrease in glucocorticoids:
• Shock, DIC, purpura, septicemia.
• Salt and water loss (decreased aldosterone) - due to destruction of mineralocorticoid aldosterone.
• Hypoglycemia, fatigue.
• Hypovolemic shock.
64
Q

What is Waterhouse-Friderichsen Syndrome?

A
  • Acute haemorrhagic necrosis (apoplexy).
  • Secondary to DIC, meningococcal meningitis, new born, trauma (in all these conditions - sudden haemorrhagic necrosis known as WF syndrome).
65
Q

Describe the pathogenesis of adrenogenital syndrome?

A

AKA congenital adrenal hyperplasia - refers to a group of inherited disorders of the adrenal gland.

  1. Autosomal recessive disorders characterised by deficiency or total lack of a particular enzyme involved in the production of cortical steroids (cortisol & aldosterone) by the adrenal gland → the most common enzyme deficiency is 21-Hydroxylase deficiency.
  2. Decreased cortisol synthesis results in increased secretion of ACTH by pituitary gland.
  3. Increased ACTH causes adrenal hyperplasia which results in androgen excess with or without aldosterone/glucocorticoid deficiency.
66
Q

Outline Addison’s disease and its clinical features.

A
  • Primary chronic adrenal insufficiency.
  • Low plasma cortisol (increased ACTH).
  • Anorexia, weight loss, vomiting, diarrhoea.
  • Weakness, lethargy, hypotension.
  • Skin pigmentation (MSH) in primary* - due to excess MSH.
  • Plasma decreased Na+ and increased K+ (opposite of hyperaldosteronism).
  • Chronic dehydration, sexual dysfunction.

• Stresses (i.e. infection) can precipitate an acute adrenal crisis:

  • Profound fatigue.
  • Dehydration.
  • Vascular collapse (decreased BP).
  • Renal shut down.
  • Decreased serum Na+ and increased serum K+.
67
Q

Identify the aetiology of Addison’s disease.

A
  • Autoimmune 70%, APS1, APS2* (autoimmune polyendocrinopathy syndromes - similar to MEN 1/2).
  • Infections (TB, fungal), tumours.
68
Q

Describe the pathogenesis of Addison’s disease.

A
  1. Progressive destruction of the adrenal cortex due to:
    - Autoimmune (sporadic, polyglandular).
    - Tuberculosis.
    - HIV/AIDS.
    - Metastatic carcinoma.
    - Bilateral adrenalectomy.
  2. Decreased production of glucocorticoids and/or mineralocorticoids (corticosteroids).
  3. Clinical manifestations don’t appear till at least 90% of adrenal cortex has been compromised.
69
Q

Outline the diagnosis of Addison’s disease.

A
  • ACTH increased (primary), decreased (secondary).
  • Low plasma cortisol.
  • ACTH stimulation test (cortisol levels fail to increase in response to exogenous ACTH).
  • Should also assess mineralocorticoid and androgen levels.
70
Q

Differentiate between hyperplasia and atrophy.

A
  • Hyperplasia - hyperactivity of the affected gland.

* Atrophy - hypoactivity of the affected gland.

71
Q

Outline pheochromocytoma.

A

• Benign tumour of adrenal medulla (extra adrenal - in paraganglia).
- Tumour of medullary chromaffin cells in the adrenal glands.
• Young age, typically produces very severe and fluctuating secondary hypertension*.
• Increased catecholamines - epinephrine.
• Very small (1g) to large tumors.
• 25% familial (MEN 2 syndrome, NF1, VHL).
• 10% extra adrenal/bilateral (MEN)/malignant/no hypertension (non functional) - 10% rule.
• Diagnosis: increased urinary VMA (vanillylmandelic acid) - metabolite of epinephrine.

72
Q

Outline primary hyperparathyroidism.

A

• Commonest parathyroid disorder - causes increased serum calcium.
• Primary: Adenoma 90% - increased PTH.
- PTH causes release of calcium from bones, absorption from urine and GIT → cause increased Ca2+ levels.
• Adults, females 4:1, asymptomatic → severe (mild to severe).
• Rarely part of MEN type 1.
• Hypercalcemia, urinary stones, bone resorption, osteoporosis, depression, seizures
• Osteitis fibrosa cystica (brown tumour of bone) in severe form (severe bone resorption).

73
Q

Outline secondary, tertiary and quaternary hyperparathyroidism.

A
  • Secondary HPT - chronic renal failure → Ca2+ loss → increased PTH.
  • Tertiary HPT - secondary + hyperplasia. Not responding to Ca2+ levels.
  • Quaternary HPT - tertiary + adenoma.
74
Q

Describe multiple endocrine neoplasia type 1 (MEN-1).

A

• Commonest.
• Gene - MEN1.
• PPPP:
- Pituitary adenoma
- Parathyroid adenoma
- Pancreas islet cell tumours (pancreatic adenoma)
- Duodenal tumour (gastrinoma causing PUD).

  • Result from inactivating mutations in MEN1 (tumour suppressor gene on chromosome 11).
  • This causes deregulation of normal gene transcription.
  • Characterised by abnormalities involving the pancreas, parathyroid and pituritary glands.
75
Q

Describe multiple endocrine neoplasia type 2 (MEN-2).

A

• Thyroid medullary carcinoma.
- 2 subtypes: type IIA and IIB.
• Gene - RET.

  • Result from mutations in the RET proto-oncogene on chromosome 10.
  • This causes constitutive activation of membrane-associated tyrosine kinase RET which controls the development of cells that migrate from the neural crest.
  • Type IIA - characterised by pheochromocytoma, medullary thyroid carcinoma and parathyroid hyperplasia.
  • Type IIB - medullary thyroid carcinoma, pheochromocytoma, neuromas of skin, GIT, eye, respiratory, oral cavity.
76
Q

Outline autoimmune polyendocrine syndrome (APS) type 1.

A

• Autoimmune destruction of endocrine glands (multiple).
• Always exclude these syndromes - involvement of multiple endocrine glands.
APS type 1:
• Autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED).
• Childhood, Addison’s, pernicious anaemia, hypoparathyroidism etc.
• Also Ab against IL-17 (fungal infections).

Multiple endocrinopathy starting in childhood effecting both adrenals (Addison’s disease), gastric (pernicious anaemia), hypoparathyroidism along with candidiasis (severe candida infections) and ectodermal dystrophy (abnormalities of ectoderm). Usually the antibody against IL-17 is the reason for fungal infection.

77
Q

Outline autoimmune polyendocrine syndrome (APS) type 2.

A

APS type 2:
• Early adult - adrenal insufficiency (Addison’s) with autoimmune thyroiditis and T1DM.

Polyendocrine autoimmune destruction but not with infection. Usually in early adult age. Adrenal insufficiency (Addison’s) with autoimmune thyroiditis and T1DM.